Biopharma Dive News Roundup: Ivonescimab Confidence Grows, Celldex Faces Setback, and HIV Treatment Innovates
admin A series of significant developments across the biopharmaceutical landscape this week has brought both renewed...
biotech
Cancer Research Institute Announces 2026 Recipients of Highest Scientific Honors in Cancer Immunotherapy
The Cancer Research Institute (CRI), a global leader in advancing immunotherapy, proudly announces the recipients...
Scribe Therapeutics Breaks Two-Year Gene Editing IPO Freeze, Raises $129 Million Amid Shifting Biotech Market Dynamics
Scribe Therapeutics, a pioneering startup focused on advanced gene editing medicines, successfully priced its initial...
Nobel Laureate Susumu Tonegawa, Pioneer of Immunological Diversity and Neuroscience, Dies at 86
The scientific community mourns the loss of Susumu Tonegawa, PhD, a towering figure in molecular...
Controversial FDA Panel Recommends Broader Use of Unproven Peptides Amidst Political Pressure and Scientific Skepticism
In a decision poised to significantly reshape the landscape of dietary supplements and compounded medications,...
Legacy of Hope: How Planned Giving to the Cancer Research Institute Propels Immunotherapy Towards a Cancer-Immune World
Including the Cancer Research Institute (CRI) in one’s will represents a profound personal commitment to...
Eli Lilly Delays Retatrutide Filing, Triple-G Drug Poised to Reshape Obesity Market Amidst Cardiovascular Questions
Eli Lilly and Company, a global pharmaceutical leader, has announced a revised timeline for the...
July Marks Ultraviolet Radiation Safety Awareness Month: A Deep Dive into Skin Cancer Prevention and Immunotherapy Breakthroughs
As July unfolds, the Cancer Research Institute (CRI) joins health organizations worldwide in observing Ultraviolet...
Potential Tariffs on Generic Pharmaceuticals Threaten Widespread Disruption to U.S. Healthcare System
The prospect of significant tariffs, potentially reaching up to 200%, on imported generic pharmaceuticals poses...
GSK Secures Landmark FDA Approval for Jideytro in ROS1-Positive Lung Cancer, Solidifying Its Ambitious Oncology Expansion
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Jideytro, a novel...
